MedTrace Logo

Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

NCT05157139 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-01-31

No results posted yet for this study

Summary

* The study is a randomized clinical trial to assess a natural formula of vanillin \& wheat germ oil to treat and stop the clinical progression of COVID-19.
* The study aims to treat people with mild-to-moderate COVID-19 before their cases become severe.
* The study duration is a 5-day experimental intervention and an extended 4 weeks follow up.

Conditions

  • Mild-to-moderate COVID-19

Interventions

DRUG

Oral Capsule

Oral Capsule of vanillin \& wheat germ oil

Sponsors & Collaborators

  • Assoc. Prof. Ayman Ibrahim Baess

    collaborator UNKNOWN

  • Dr. Noha Alaa Eldine Hassan Hamdy

    collaborator UNKNOWN

  • Ph. Hanya Hesham Sweilam

    collaborator UNKNOWN

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-03-31
Completion
2022-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05157139 on ClinicalTrials.gov